BIOKANGTAI Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 1,902

Employees

  • Stock Symbol
  • 300601

Stock Symbol

  • Share Price
  • $2.02
  • (As of Wednesday Closing)

BIOKANGTAI General Information

Description

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SHE
Corporate Office
  • No.18,Shutianpu Road
  • Guangming District
  • Shenzhen, Guangdong 518107
  • China
+86 0755 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIOKANGTAI Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.02 $2.07 $2.01 - $4.82 $2.25B 1.12B 9.6M $0.09

BIOKANGTAI Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 3,569,785 4,453,056 5,181,792 10,350,430
Revenue 444,822 491,519 468,837 565,595
EBITDA 107,055 161,105 (23,899) 276,217
Net Income 99,280 121,741 (19,706) 195,658
Total Assets 2,110,749 2,128,115 1,998,225 2,219,762
Total Debt 369,922 347,682 331,825 429,567
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BIOKANGTAI Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BIOKANGTAI‘s full profile, request access.

Request a free trial

BIOKANGTAI Patents

BIOKANGTAI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021105902-A4 Tetravalent influenza virus chicken embryo culture processes, tetravalent influenza virus split vaccines and preparation methods thereof Active 19-Aug-2021 00000000
AU-2021107276-A4 Purification process of chicken embryo allantoic fluid of tetravalent influenza virus, tetravalent influenza virus split vaccine and preparation method thereof Active 29-Dec-2020 000000000

BIOKANGTAI Board Members (2)

Name Representing Role Since
Weimin Du BIOKANGTAI Chairman & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

BIOKANGTAI Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BIOKANGTAI Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BIOKANGTAI‘s full profile, request access.

Request a free trial

BIOKANGTAI ESG

Risk Overview

Risk Rating

Updated May, 31, 2024

30.32 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Biotechnology

Subindustry

00 of 405

Rank

00.00

Percentile

To view BIOKANGTAI’s complete esg history, request access »

BIOKANGTAI FAQs

  • When was BIOKANGTAI founded?

    BIOKANGTAI was founded in 1992.

  • Where is BIOKANGTAI headquartered?

    BIOKANGTAI is headquartered in Shenzhen, China.

  • What is the size of BIOKANGTAI?

    BIOKANGTAI has 1,902 total employees.

  • What industry is BIOKANGTAI in?

    BIOKANGTAI’s primary industry is Biotechnology.

  • Is BIOKANGTAI a private or public company?

    BIOKANGTAI is a Public company.

  • What is BIOKANGTAI’s stock symbol?

    The ticker symbol for BIOKANGTAI is 300601.

  • What is the current stock price of BIOKANGTAI?

    As of 24-Jul-2024 the stock price of BIOKANGTAI is $2.02.

  • What is the current market cap of BIOKANGTAI?

    The current market capitalization of BIOKANGTAI is $2.25B.

  • What is BIOKANGTAI’s current revenue?

    The trailing twelve month revenue for BIOKANGTAI is $445M.

  • What is BIOKANGTAI’s annual earnings per share (EPS)?

    BIOKANGTAI’s EPS for 12 months was $0.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »